There are many success stories of generic companies becoming a billion dollar company in a short span of time, over the past 20 years we have seen that many generics companies became public in duration of 7-9 years, it’s a great achievement of these companies.
As the competition is becoming tough day by day between the innovator companies and the generics, I feel that big daddy's such as Pfizer, GSK, J&J, and Merck will soon perhaps in coming quater or year/next decade will strategise their deal towards acquiring medium to average size (200-800M revenue) generic or bio similar companies.
What do you people feel about it, share your thoughts.......
No comments:
Post a Comment